A Comparison of the LMA Unique and LMA Supreme in Children

October 4, 2011 updated by: Narasimhan Jagannathan, Ann & Robert H Lurie Children's Hospital of Chicago

A Prospective, Randomized Comparison of the LMA Unique and LMA Supreme in Children

The goal of this study is to compare the LMA Unique and LMA Supreme in children having surgery. We hypothesize that the airway leak pressures with the LMA Supreme will be superior to the LMA Unique. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use, and complications (airway related, gastric insufflation, trauma) will also be assessed.

Study Overview

Status

Completed

Conditions

Detailed Description

The LMA Supreme is a newer version of the current model, the laryngeal mask airway Unique. Both models are approved for use by the FDA, and are routinely used for airway management during general anesthesia. Three main features distinguish the laryngeal mask airway Supreme from the original LMA: i) a curved rigid airway tube, ii) provision for a gastric drain tube, and iii) a larger mask for improved fit and airway seal.

The aim of this randomized prospective study is to compare two types of the laryngeal mask airway: the laryngeal mask airway Unique and the laryngeal mask airway Supreme, in pediatric patients without the use of neuromuscular blockade. Based on the design features listed above, we hypothesize that the airway leak pressures with the LMA Supreme will be superior to the LMA Unique. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use, and complications (airway related, gastric insufflation, trauma) will also be assessed.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60614
        • Childrens Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 6 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Children weighing 10 to 25 kg undergoing surgical or medical procedures under anesthesia requiring a supraglottic airway device

Description

Inclusion Criteria:

  • Children undergoing general anesthesia using a supraglottic airway device
  • weight 10-25kg
  • age 6 months-6 years

Exclusion Criteria:

ASA class IV, V Emergency procedures

  • History of a difficult airway
  • Active gastrointestinal reflux
  • Active upper respiratory tract infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
LMA Supreme
LMA unique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Airway leak pressure
Time Frame: after placement of the supraglottic airway device/ Participants will be followed 24 hours postoperatively
Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed completely.
after placement of the supraglottic airway device/ Participants will be followed 24 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fiberoptic grade of laryngeal view
Time Frame: After placement of the supraglottic device
The laryngeal alignment through the devices will be graded using an established scoring system
After placement of the supraglottic device
Adverse effects
Time Frame: Participants will be followed 24 hours postoperatively
complications such as oxygen desaturations, mucosal trauma, reflex activation of the airway, sore throat, dysphonia will be recorded
Participants will be followed 24 hours postoperatively
Time to secure the airway
Time Frame: after placement of the supraglottic airway device
From picking up the airway device to bilateral chest expansion and presence of ETCO2
after placement of the supraglottic airway device
Number of attempts to place the device
Time Frame: at the beginning of anesthesia
number of attempts needed for successful placement will be recorde (maximum of 3 attempts will be considered as a failure)
at the beginning of anesthesia
Fiberoptic view through the gastric tube
Time Frame: After placement of the LMA supreme
The view through the gastric drain tube of the LMA supreme will be assessed and graded using an established scoring system
After placement of the LMA supreme
Ease of gastric tube placement
Time Frame: After placement of the LMA supreme
The ease of gastric placement will be assessed using a subjective scale
After placement of the LMA supreme
Gastric insufflation
Time Frame: During leak pressure testing
The presence of gastric insufflations will be assessed during leak pressure testing by using epigastric auscultation
During leak pressure testing
Quality of the airway
Time Frame: During maintenance of anesthesia
The quality of hands free anesthesia will be assessed during maintenance of anesthesia using a previously described scale
During maintenance of anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Actual)

September 1, 2011

Study Completion (Actual)

September 1, 2011

Study Registration Dates

First Submitted

August 3, 2011

First Submitted That Met QC Criteria

August 3, 2011

First Posted (Estimate)

August 4, 2011

Study Record Updates

Last Update Posted (Estimate)

October 5, 2011

Last Update Submitted That Met QC Criteria

October 4, 2011

Last Verified

October 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • LMA unique vs LMA supreme

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

3
Subscribe